BRPI0815180A2 - hindantoinas substituídas - Google Patents
hindantoinas substituídasInfo
- Publication number
- BRPI0815180A2 BRPI0815180A2 BRPI0815180A BRPI0815180A BRPI0815180A2 BR PI0815180 A2 BRPI0815180 A2 BR PI0815180A2 BR PI0815180 A BRPI0815180 A BR PI0815180A BR PI0815180 A BRPI0815180 A BR PI0815180A BR PI0815180 A2 BRPI0815180 A2 BR PI0815180A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- hindantoins
- substituted
- mek2
- mek
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95614507P | 2007-08-16 | 2007-08-16 | |
PCT/EP2008/060326 WO2009021887A1 (en) | 2007-08-16 | 2008-08-06 | Substituted hydantoins |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815180A2 true BRPI0815180A2 (pt) | 2019-09-24 |
Family
ID=39830023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815180A BRPI0815180A2 (pt) | 2007-08-16 | 2008-08-06 | hindantoinas substituídas |
Country Status (12)
Country | Link |
---|---|
US (1) | US7557221B2 (pt) |
EP (1) | EP2188276B1 (pt) |
JP (1) | JP2010536723A (pt) |
KR (1) | KR101147583B1 (pt) |
CN (1) | CN101778839A (pt) |
AT (1) | ATE551336T1 (pt) |
AU (1) | AU2008288556A1 (pt) |
BR (1) | BRPI0815180A2 (pt) |
CA (1) | CA2695956A1 (pt) |
ES (1) | ES2383927T3 (pt) |
MX (1) | MX2010001581A (pt) |
WO (1) | WO2009021887A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102020651B (zh) | 2010-11-02 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 6-芳基氨基吡啶酮甲酰胺mek抑制剂 |
CA2843595C (en) | 2011-08-01 | 2022-10-18 | Genentech, Inc. | Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors |
US20150265679A1 (en) | 2012-11-02 | 2015-09-24 | The United States Of America, As Represented By Secretary, Department Of Health And Human Services | Method of reducing adverse effects in a cancer patient undregoing treatment with a mek inhibitor |
AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
EP3055287B1 (en) * | 2013-10-08 | 2019-11-06 | Lu, Qing-Bin | Non-platinum-based anti-cancer compounds for use in targeted chemotherapy |
SG11201700074YA (en) | 2014-07-15 | 2017-02-27 | Genentech Inc | Compositions for treating cancer using pd-1 axis binding antagonists and mek inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE277895T1 (de) | 1997-07-01 | 2004-10-15 | Warner Lambert Co | 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren |
KR19990012061A (ko) | 1997-07-26 | 1999-02-25 | 성재갑 | 파네실 전이효소 저해제로 유용한 하이덴토인 유도체 |
ATE304011T1 (de) | 2000-05-03 | 2005-09-15 | Hoffmann La Roche | Hydantoin-enthaltende glucokinase aktivatoren |
US7235537B2 (en) | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
DE602004023207D1 (de) * | 2003-07-24 | 2009-10-29 | Warner Lambert Co | Benzimidazol-derivate als mek-hemmer |
CA2557398A1 (en) * | 2004-02-26 | 2005-09-09 | Hans-Peter Buchstaller | Benzimidazolyl derivatives as kinase inhibitors |
ATE404556T1 (de) * | 2004-08-17 | 2008-08-15 | Hoffmann La Roche | Substituierte hydantoine |
TW200621766A (en) | 2004-09-17 | 2006-07-01 | Hoffmann La Roche | Substituted hydantoins |
WO2006124780A2 (en) | 2005-05-12 | 2006-11-23 | Kalypsys, Inc. | Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
US7612212B2 (en) * | 2006-02-22 | 2009-11-03 | Hoffmann-La Roche Inc. | Substituted hydantoins |
-
2008
- 2008-08-06 WO PCT/EP2008/060326 patent/WO2009021887A1/en active Application Filing
- 2008-08-06 KR KR1020107003298A patent/KR101147583B1/ko not_active IP Right Cessation
- 2008-08-06 AT AT08786933T patent/ATE551336T1/de active
- 2008-08-06 ES ES08786933T patent/ES2383927T3/es active Active
- 2008-08-06 MX MX2010001581A patent/MX2010001581A/es active IP Right Grant
- 2008-08-06 BR BRPI0815180A patent/BRPI0815180A2/pt not_active IP Right Cessation
- 2008-08-06 AU AU2008288556A patent/AU2008288556A1/en not_active Abandoned
- 2008-08-06 US US12/186,648 patent/US7557221B2/en not_active Expired - Fee Related
- 2008-08-06 JP JP2010520534A patent/JP2010536723A/ja active Pending
- 2008-08-06 CA CA2695956A patent/CA2695956A1/en not_active Abandoned
- 2008-08-06 CN CN200880102760A patent/CN101778839A/zh active Pending
- 2008-08-06 EP EP08786933A patent/EP2188276B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
ATE551336T1 (de) | 2012-04-15 |
WO2009021887A1 (en) | 2009-02-19 |
ES2383927T3 (es) | 2012-06-27 |
JP2010536723A (ja) | 2010-12-02 |
KR20100031777A (ko) | 2010-03-24 |
EP2188276A1 (en) | 2010-05-26 |
MX2010001581A (es) | 2010-03-15 |
KR101147583B1 (ko) | 2012-05-21 |
US20090048452A1 (en) | 2009-02-19 |
US7557221B2 (en) | 2009-07-07 |
EP2188276B1 (en) | 2012-03-28 |
CN101778839A (zh) | 2010-07-14 |
CA2695956A1 (en) | 2009-02-19 |
AU2008288556A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201100580A1 (ru) | Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы | |
EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
MX2009012066A (es) | Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k. | |
MX2009011964A (es) | Derivados heterociclicos pirrolo-nitrogenosos, su preparacion y uso farmaceutico. | |
EA200970557A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
BRPI0512547A (pt) | pirimidinas | |
EA200800664A1 (ru) | Производные пирролопиримидина в качестве ингибиторов syk | |
GEP20135785B (en) | Pyrrolopyrimidine compounds as cdk inhibitors | |
BRPI0608886B8 (pt) | derivados de n-sulfonilpirróis e seus usos | |
EA200800201A1 (ru) | Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида | |
NO20075987L (no) | Bisykliske derviater som p38-kinaseinhibitorer | |
NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
EA200901483A1 (ru) | ПРОИЗВОДНЫЕ ПИРИМИДИНА И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
BRPI0815180A2 (pt) | hindantoinas substituídas | |
EA200700220A1 (ru) | Имидазотриазины в качестве ингибиторов протеинкиназы | |
EA200601568A1 (ru) | Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4 | |
ATE469154T1 (de) | Pyrazolopyrimidine als zellzyklus-kinasehemmer | |
ATE469158T1 (de) | Heteroalkylgebundene pyrimidinderivate | |
EA201790678A1 (ru) | Бициклические гетероарильные соединения | |
NO20074391L (no) | CIS-2,4,5-triaryl-imidazoliner og deres anvendelse som anti-cancer medikamenter | |
GEP20094785B (en) | Pyrrolopyrazoles, potent kinase inhibitors | |
NO20070526L (no) | Kinazolindionderivater som parp-inhibitorer | |
MX2009004623A (es) | Imidazopiridazinas como inhibidores de la lipido cinasa pi3k. | |
ATE471324T1 (de) | Triazolophthalazine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |